Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Rapid effects of deep brain stimulation for treatment-resistant major depression.

Schlaepfer TE, Bewernick BH, Kayser S, Mädler B, Coenen VA.

Biol Psychiatry. 2013 Jun 15;73(12):1204-12. doi: 10.1016/j.biopsych.2013.01.034. Epub 2013 Apr 3. Review.

PMID:
23562618
2.

Antidepressant effects after short-term and chronic stimulation of the subgenual cingulate gyrus in treatment-resistant depression.

Merkl A, Schneider GH, Schönecker T, Aust S, Kühl KP, Kupsch A, Kühn AA, Bajbouj M.

Exp Neurol. 2013 Nov;249:160-8. doi: 10.1016/j.expneurol.2013.08.017. Epub 2013 Sep 5.

PMID:
24012926
3.

Deep brain stimulation of the medial forebrain bundle: Distinctive responses in resistant depression.

Fenoy AJ, Schulz P, Selvaraj S, Burrows C, Spiker D, Cao B, Zunta-Soares G, Gajwani P, Quevedo J, Soares J.

J Affect Disord. 2016 Oct;203:143-151. doi: 10.1016/j.jad.2016.05.064. Epub 2016 Jun 3.

PMID:
27288959
4.

A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle.

Jiménez F, Velasco F, Salin-Pascual R, Hernández JA, Velasco M, Criales JL, Nicolini H.

Neurosurgery. 2005 Sep;57(3):585-93; discussion 585-93.

PMID:
16145540
5.

Medial forebrain bundle stimulation-speed access to an old or entry into a new depression neurocircuit?

Sartorius A, Hoyer C, Kiening K, Meyer-Lindenberg A.

Biol Psychiatry. 2013 Dec 15;74(12):e43. doi: 10.1016/j.biopsych.2013.05.041. Epub 2013 Aug 2. No abstract available.

PMID:
23916390
6.

Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.

Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS.

Int Clin Psychopharmacol. 2008 Jan;23(1):29-35.

PMID:
18090505
7.

Reply to: medial forebrain bundle stimulation-speed access to an old or entry into a new depression neurocircuit?

Coenen VA, Mädler B, Schlaepfer TE.

Biol Psychiatry. 2013 Dec 15;74(12):e45-6. doi: 10.1016/j.biopsych.2013.06.017. Epub 2013 Aug 2. No abstract available.

PMID:
23916389
8.

Deep brain stimulation for treatment-resistant depression.

Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH.

Neuron. 2005 Mar 3;45(5):651-60.

9.

Vagus nerve stimulation in treatment-resistant depression: acute and follow-up results of an italian case series.

Dell'Osso B, Oldani L, Palazzo MC, Balossi I, Ciabatti M, Altamura AC.

J ECT. 2013 Mar;29(1):41-4. doi: 10.1097/YCT.0b013e3182735ef0.

PMID:
23303420
10.

Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design.

Goodman WK, Foote KD, Greenberg BD, Ricciuti N, Bauer R, Ward H, Shapira NA, Wu SS, Hill CL, Rasmussen SA, Okun MS.

Biol Psychiatry. 2010 Mar 15;67(6):535-42. doi: 10.1016/j.biopsych.2009.11.028. Epub 2010 Feb 8.

PMID:
20116047
11.

Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study.

Martin DM, Alonzo A, Mitchell PB, Sachdev P, Gálvez V, Loo CK.

J Affect Disord. 2011 Nov;134(1-3):459-63. doi: 10.1016/j.jad.2011.05.018.

PMID:
21641047
12.

Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

Matsunaga M, Okamoto Y, Suzuki S, Kinoshita A, Yoshimura S, Yoshino A, Kunisato Y, Yamawaki S.

BMC Psychiatry. 2010 Mar 16;10:22. doi: 10.1186/1471-244X-10-22.

13.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.

Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.

J Clin Psychiatry. 2008 Feb;69(2):183-9.

PMID:
18211128
14.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW.

J Clin Psychopharmacol. 2008 Dec;28(6):631-7. doi: 10.1097/JCP.0b013e31818a6cea.

PMID:
19011431
15.
16.

Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.

Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP.

J Clin Psychiatry. 2011 Oct;72(10):1376-82. doi: 10.4088/JCP.09m05888blu.

PMID:
21295002
17.

The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder.

Coenen VA, Schlaepfer TE, Goll P, Reinacher PC, Voderholzer U, Tebartz van Elst L, Urbach H, Freyer T.

CNS Spectr. 2017 Jun;22(3):282-289. doi: 10.1017/S1092852916000286. Epub 2016 Jun 8.

PMID:
27268576
18.

Pilot study of deep brain stimulation in refractory obsessive-compulsive disorder ethnic Chinese patients.

Tsai HC, Chang CH, Pan JI, Hsieh HJ, Tsai ST, Hung HY, Chen SY.

Psychiatry Clin Neurosci. 2012 Jun;66(4):303-12. doi: 10.1111/j.1440-1819.2012.02352.x.

19.

Deep brain stimulation to the medial forebrain bundle for depression- long-term outcomes and a novel data analysis strategy.

Bewernick BH, Kayser S, Gippert SM, Switala C, Coenen VA, Schlaepfer TE.

Brain Stimul. 2017 May - Jun;10(3):664-671. doi: 10.1016/j.brs.2017.01.581. Epub 2017 Feb 9.

PMID:
28259544
20.

Deep brain stimulation for major depression.

Schlaepfer TE, Bewernick BH.

Handb Clin Neurol. 2013;116:235-43. doi: 10.1016/B978-0-444-53497-2.00018-8. Review.

PMID:
24112897

Supplemental Content

Support Center